Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Golden Sun Biochemical Pharmaceutical is a specialized pharmaceutical manufacturer based in Fuyang, China, focusing on the development and production of biochemical drugs and active pharmaceutical ingredients (APIs). The company is a prominent producer of heparin-related products, including Heparin Sodium and low-molecular-weight heparins such as Enoxaparin and Dalteparin. It operates large-scale, GMP-compliant manufacturing facilities and supplies anticoagulants to both the Chinese domestic market and international clients. Beyond its core heparin portfolio, the company produces various biochemical extracts and finished dosage forms for cardiovascular and hematological therapeutic areas. As a key subsidiary of the Anhui Golden Sun Group, it is recognized as a high-tech enterprise in the Anhui province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Golden Sun Biochemical Pharmaceutical.